Physician profile
David Lee
NPI 1447297205
$1,759.49
in general payments reported to CMS, 2019-2025
13 companies · $158 in 2025
The $158 reported for 2025 was more than what 76% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $228 · 2021: $278 · 2022: $606 · 2023: $125 · 2024: $190 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $482.92 | 2022-2025 | Impella |
| Abbvie INC. | $458.14 | 2021-2022 | |
| Edwards Lifesciences Corporation | $335.87 | 2019-2022 | |
| Allergan, INC. | $202.11 | 2019-2021 | |
| Octapharma USA, INC. | $114.56 | 2025 | Fibryga |
| Medtronic, INC. | $33.51 | 2022 | |
| Merck Sharp & Dohme LLC | $28.15 | 2020 | |
| Abbott Laboratories | $26.13 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $19.49 | 2020 | |
| Amneal Pharmaceuticals LLC | $17.66 | 2020 | |
| Portola Pharmaceuticals, LLC | $15.40 | 2019 | |
| Avanos Medical | $14.40 | 2022 | |
| Chiesi USA, INC. | $11.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.